Cipla's Umang Vohra on Q2 performance and outlook going forward

Name: Cipla's Umang Vohra on Q2 performance and outlook going forward
Uploaded: 2019-11-07T05:54:00+00:00
Duration: 8 min 27 s
Channel: CNBC-TV18
Description: Detailing the third quarter performance and outlook going forward Umang Vohra, MD & Global CEO, Cipla said the trade generic segment has recovered and grew 60 percent versus quarter one. The branded Rx prescription business by 13 percent, he said.

CNBC-TV18

Detailing the third quarter performance and outlook going forward Umang Vohra, MD & Global CEO, Cipla said the trade generic segment has recovered and grew 60 percent versus quarter one. The branded Rx prescription business by 13 percent, he said.

Featured channels